An experimental weight-loss pill is showing promising results, helping people drop 13% of their body weight in a three-month period. The results from early clinical trials were presented by Novo Nordisk — the Danish drugmaker behind Ozempic and Wegovy — at the European Association for the Study of Diabetes (EASD) annual meeting in Madrid this...
There may be a “promising new strategy” in combating aggressive forms of prostate cancer, according to a new study. Researchers at Flinders University and the University of South Australia investigated how the novel drug, CDKI-73, has the potential to tackle drug-resistant prostate cancer. This drug reportedly “defies conventional therapies,” as noted in the study findings,...
The pandemic’s negative effects on kids and teens — academically, socially and otherwise — have been shown in numerous studies, and now the latest long-term effect appears to be accelerated aging of young brains. A team of researchers at the University of Washington studied 160 teens between the ages of 9 and 17. They had...
EXCLUSIVE: The House Oversight Committee says it is aware of a machine operated by a Chinese military company that is in use at the nation’s most secretive government laboratories. “We are aware that there is a BGI machine at Los Alamos,” a committee spokeswoman told Fox News Digital. Situated in rural New Mexico, Los Alamos...
New research from the American Heart Association (AHA) suggests that parents might want to keep a closer eye on their kids’ blood pressure. About one in seven (14%) of children and teens in the U.S. have high blood pressure or are headed toward it, according to the preliminary findings. Nearly half of U.S. adults have...
Gut health has been linked to a common neurological disorder in a new study. Those who have sustained damage to the upper lining of their gastrointestinal (GI) tract are 76% more likely to develop Parkinson’s disease, according to research led by Beth Israel Deaconess Medical Center (BIDMC) in Boston. The findings were published in JAMA...
Exposure to outdoor light at night could put people at a higher risk of developing Alzheimer’s disease (AD), according to a new study published in Frontiers in Neuroscience. “We show that, in the U.S., there is a positive association between AD prevalence and exposure to light at night, particularly in those under the age of...
Scientists at Stanford University were recently able to make a mouse’s skin transparent using a common food dye, something the study’s author told Fox News Digital could have exciting benefits for humans once additional research is conducted. The paper, titled “Achieving optical transparency in live animals with absorbing molecules,” was published in the journal “Science”...
New technology could make it significantly easier to monitor patients’ vital health signs. Engineers at the University of California San Diego have developed an electronic finger wrap that monitors important chemical levels — such as glucose, vitamins and even drugs — using only human sweat, the university stated in a news release. The wearable innovation...
A drug called ribociclib, currently used to treat breast cancer, could slow the progression of certain pediatric high-grade gliomas, an aggressive type of childhood brain cancer, a new study has found. Ribociclib (brand name Kisqali) is a CDK4/6 inhibitor, a type of drug that targets specific enzymes — including the protein CDK6 — to stop...
